Our impact

Man running outside
style
background-none
additionalPadding
none
additionalMargin
none
style
background-none

Our goal is to create medicines that make life better

We work every day with the goal of growing our business in responsible and sustainable ways that better people’s lives and benefit society.
Our impact starts with the purpose of our business: to create medicines that make life better. We’re committed to expanding equitable access to medicines for more people around the world, and we are working to improve public health for vulnerable people living in areas with limited resources. We further aim to extend our impact by strengthening communities and addressing social issues – like social determinants of health and education – that matter to our business, employees and society.
extra-styles
offset
style
two-col-75-25
style
background-none

Building on our purpose, we focus our impact efforts on five key areas

Across these areas, we set and measure challenging goals to continually improve what we do – and how we do it. We discuss those goals throughout this section and website. See Lilly's Sustainability Report for detailed information about our social impact and environmental, social and governance work.
Prescription icon

Increase access to medicines

tile, title-fs-32px
Globe icon

Minimise our environmental impact

tile, title-fs-32px
Three users icon

Improve lives and communities

tile, title-fs-32px
stethoscope icon

Cultivate an inclusive culture

tile, title-fs-32px
scale icon

Operate ethically and responsibly

tile, title-fs-32px
style
background-tertiary-blue
additionalPadding
narrow
KEY AREAS OF FOCUS

At the Heart of Our Impact Is Our Purpose

Over 71 million people count on Lilly medicines each year1. In the 150+ years we’ve been in business, we’ve developed and delivered medicines that help people get better, feel better and live better.
style
background-none
additionalPadding
narrow
Prescription icon

Dedicated to Increasing Access to Medicines

30 x 30
Improving access to quality health care for
30 million people living in resource-
limited settings, annually, by 20301
Too many people, especially the most vulnerable, lack access to the medicines and care they need. Reaching across industry boundaries, we work with leading health organisations, providers, regulators and governments to find new solutions that help address access challenges and strengthen health care systems.

We have established a comprehensive goal - Lilly 30x30 - to improve access to quality health care for 30 million people living in communities with limited resources, annually by 2030.
style
background-none, two-col-50-50
extra-styles
offset
style
background-none

OUR 2030 ENVIRONMENTAL GOALS

Minimise our
environmental impact

Making medicines requires the use of valuable resources including energy, water and raw materials. We’re committed to continually improving our environmental impact across our product life cycles and supply chain. We have set new sustainability goals to reduce our emissions and waste and to continue using water responsibly and efficiently.
cloudfog icon

Climate

tile, title-fs-32px, description-fs-20px

Carbon neutral in our own operations

100% renewable electricity

Enhance full value-chain emissions reporting

trash icon

Waste

tile, title-fs-32px, description-fs-20px

Zero waste to landfills from routine operations

100% of plastic waste for beneficial use, with at least 90% recycled or reused

Integrate sustainability into product and packaging design

water droplet icon

Water

tile, title-fs-32px, description-fs-20px

No adverse impact to water-stressed areas

No adverse impact from pharmaceuticals in the environment

style
background-primary-red
additionalPadding
narrow
Woman and Girl cooking together
Three users icon

We’re Improving Lives and Communities

We invest our time, expertise and resources to drive social impact, with a focus on improving health, education and equity. We encourage our employees to volunteer and give in ways that advance our purpose and are meaningful to them.
Woman with dark hair laughing
Stethoscope icon

We’re Cultivating an Inclusive Culture

Cultivating an inclusive culture enables us to attract and keep the best talent, fuels innovation necessary for the next breakthrough medicine, and strengthens our understanding of the patients who depend on us. We deeply value diverse backgrounds, skills and global perspectives, and will continue to be guided by our core values of integrity, excellence and respect for people.
Learn more about our inclusion efforts
additionalPadding
narrow
additionalMargins
narrow

Everything We Do Starts with Operating
Ethically and Responsibly

It’s who we are. It’s the foundation of how we conduct business and create positive change for people and communities, while reducing our environmental impact. The Lilly family’s core values of integrity, excellence and respect for people have guided us since the beginning, and they remain at the heart of all we do today.
false
Two girls running outside
Scales light icon
additionalPadding
none
additionalMargins
none
Woman sitting on sofa looking into the distance

2025 Year in Review

card, titleone-fs-32px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-uk, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Explore Our Highlights
Man bent over working out

Sustainability Report

card, titleone-fs-32px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-uk, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
View the Full Report
style
background-none
additionalPadding
narrow

Lilly Cautionary Statement Regarding Forward-Looking Statements

This website contains forward-looking statements that are based on management’s assumptions and expectations at the time the statements were posted, including statements regarding our sustainability targets, goals, commitments and programs and other business plans, initiatives, aspirations and objectives. The words “estimate”, “project”, “intend”, “expect”, “believe”, “target”, “anticipate” and similar expressions are intended to identify forward-looking statements. All such statements are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially due to various factors. The company’s sustainability targets, goals, and commitments outlined in this website or elsewhere, as well as its operations, results, business, goals, and strategy may be affected by factors including, but not limited to, the impact of the evolving COVID-19 pandemic (or any other public health threat) and the global response thereto; the significant costs and uncertainties in the pharmaceutical research and development process, including with respect to the timing and process of obtaining regulatory approvals; competitive developments affecting current products and the company’s pipeline; regulatory actions regarding currently marketed products; litigation, investigations, or other similar proceedings involving past, current, or future products or commercial activities as the company is largely self-insured; the impact and outcome of business development transactions and related integration costs; the impact of global macroeconomic conditions, trade disruptions, disputes, unrest, war or other costs or uncertainties related to doing business in foreign jurisdictions; issues with product supply and regulatory approvals stemming from manufacturing difficulties, disruptions or shortages, including as a result of demand, labor shortages, third-party performance or regulatory actions relating to our facilities; and changes or developments in laws and regulations, including health care reform.

For additional information about the factors that affect the company’s business, please see the company’s latest Forms 10-K, 10-Q, and any 8-Ks filed with the Securities and Exchange Commission. The company expressly disclaims any obligation to update forward-looking statements except as required by applicable law.

Reference

  1. Potter L. What is in Eli Lilly and Company’s 2025 Year in Review Report? Healthcare Digital. 25 Mar 2026. [accessed 30 Mar 2026] Available from: https://healthcare-digital.com/news/what-is-in-eli-lilly-companys-2025-year-in-review-report
CMAT-06509 April 2026
additionalPadding
narrow